Study Title | PNOC019: A Randomized Double-Blinded Pilot Trial of Neoadjuvant Checkpoint Inhibition followed by Combination Adjuvant Checkpoint Inhibition in Children and Young Adults with High Grade Glioma (HGG) |
---|---|
Protocol ID | PNOC019 |
Disease (Sub Disease) | Glioblastoma Malignant Glioma Recurrent Glioblastoma Recurrent Malignant Glioma Recurrent Grade III Glioma Grade III Glioma |
Diagnosis Stage | Relapsed/Recurrent |
Sponsor | Australian and New Zealand Children's Haematology Oncology Group/ Pacific Pediatric Neuro-Oncology Consortium |
Collaborators | Bristol-Myers Squibb |
Links | https://clinicaltrials.gov/ct2/show/NCT04323046 |
Trial Status | Temporarily Closed |
Trial Open Date | 01/03/2021 |
Sites | Perth Children's Hospital / The Children's Hospital at Westmead/ Queensland Children's Hospital / Royal Children's Hospital / Women's and Children's Hospital |
Study Type | Treatment |
Phase | Pilot |
Age Eligibility | 6 Months to 22 Years |
International registry ID's | NCT04323046 |